Reports

Industry Research Reports

Global Drug-releasing Pump Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Drug-releasing Pump Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published Date: 2025-11-02

Pages: 165 Pages

Report ld: 5343274

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Drug-releasing Pump market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Drug-releasing Pump market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Medtronic
  • Johnson & Johnson
  • Roche
  • SOOIL
  • Tandem Diabetes care
  • Insulet Corp
  • Valeritas
  • Microport
  • Celanese Healthcare
  • Sonceboz
  • Enable Injections
  • Ypsomed

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Open-loop System
  • Close-loop System

Segment by Application

  • Public Hospital
  • Private Hospital

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Drug-releasing Pump study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

marn_i1

Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

marn_i1

Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

marn_i1

Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

marn_i1

Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.

marn_i1

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Drug-releasing Pump: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Drug-releasing Pump Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Open-loop System

1.2.3 Close-loop System

1.3 Market Segmentation by Application

1.3.1 Global Drug-releasing Pump Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Public Hospital

1.3.3 Private Hospital

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Drug-releasing Pump Revenue Estimates and Forecasts 2020-2031

2.2 Global Drug-releasing Pump Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Drug-releasing Pump Sales Estimates and Forecasts 2020-2031

2.4 Global Drug-releasing Pump Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

muLu

3 Competition by Manufacturers

3.1 Global Drug-releasing Pump Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Drug-releasing Pump Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Open-loop System Market Size by Manufacturers

3.5.2 Close-loop System Market Size by Manufacturers

3.6 Global Drug-releasing Pump Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

4 Global Product Segmentation Analysis

4.1 Global Drug-releasing Pump Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Drug-releasing Pump Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

muLu

5 Global Downstream Application Analysis

5.1 Global Drug-releasing Pump Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Drug-releasing Pump Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

muLu

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Drug-releasing Pump Sales and Revenue by Type (2020-2031)

6.4 North America Drug-releasing Pump Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Drug-releasing Pump Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

muLu

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Drug-releasing Pump Sales and Revenue by Type (2020-2031)

7.4 Europe Drug-releasing Pump Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Drug-releasing Pump Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

muLu

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Drug-releasing Pump Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Drug-releasing Pump Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Drug-releasing Pump Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

muLu

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Drug-releasing Pump Sales and Revenue by Type (2020-2031)

9.4 Central and South America Drug-releasing Pump Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Drug-releasing Pump Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

muLu

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Drug-releasing Pump Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Drug-releasing Pump Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Drug-releasing Pump Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

muLu

11 Corporate Profile

11.1 Medtronic

11.1.1 Medtronic Corporation Information

11.1.2 Medtronic Business Overview

11.1.3 Medtronic Drug-releasing Pump Product Models, Descriptions and Specifications

11.1.4 Medtronic Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Medtronic Drug-releasing Pump Sales by Product in 2024

11.1.6 Medtronic Drug-releasing Pump Sales by Application in 2024

11.1.7 Medtronic Drug-releasing Pump Sales by Geographic Area in 2024

11.1.8 Medtronic Drug-releasing Pump SWOT Analysis

11.1.9 Medtronic Recent Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Corporation Information

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Drug-releasing Pump Product Models, Descriptions and Specifications

11.2.4 Johnson & Johnson Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Johnson & Johnson Drug-releasing Pump Sales by Product in 2024

11.2.6 Johnson & Johnson Drug-releasing Pump Sales by Application in 2024

11.2.7 Johnson & Johnson Drug-releasing Pump Sales by Geographic Area in 2024

11.2.8 Johnson & Johnson Drug-releasing Pump SWOT Analysis

11.2.9 Johnson & Johnson Recent Developments

11.3 Roche

11.3.1 Roche Corporation Information

11.3.2 Roche Business Overview

11.3.3 Roche Drug-releasing Pump Product Models, Descriptions and Specifications

11.3.4 Roche Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Roche Drug-releasing Pump Sales by Product in 2024

11.3.6 Roche Drug-releasing Pump Sales by Application in 2024

11.3.7 Roche Drug-releasing Pump Sales by Geographic Area in 2024

11.3.8 Roche Drug-releasing Pump SWOT Analysis

11.3.9 Roche Recent Developments

11.4 SOOIL

11.4.1 SOOIL Corporation Information

11.4.2 SOOIL Business Overview

11.4.3 SOOIL Drug-releasing Pump Product Models, Descriptions and Specifications

11.4.4 SOOIL Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 SOOIL Drug-releasing Pump Sales by Product in 2024

11.4.6 SOOIL Drug-releasing Pump Sales by Application in 2024

11.4.7 SOOIL Drug-releasing Pump Sales by Geographic Area in 2024

11.4.8 SOOIL Drug-releasing Pump SWOT Analysis

11.4.9 SOOIL Recent Developments

11.5 Tandem Diabetes care

11.5.1 Tandem Diabetes care Corporation Information

11.5.2 Tandem Diabetes care Business Overview

11.5.3 Tandem Diabetes care Drug-releasing Pump Product Models, Descriptions and Specifications

11.5.4 Tandem Diabetes care Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Tandem Diabetes care Drug-releasing Pump Sales by Product in 2024

11.5.6 Tandem Diabetes care Drug-releasing Pump Sales by Application in 2024

11.5.7 Tandem Diabetes care Drug-releasing Pump Sales by Geographic Area in 2024

11.5.8 Tandem Diabetes care Drug-releasing Pump SWOT Analysis

11.5.9 Tandem Diabetes care Recent Developments

11.6 Insulet Corp

11.6.1 Insulet Corp Corporation Information

11.6.2 Insulet Corp Business Overview

11.6.3 Insulet Corp Drug-releasing Pump Product Models, Descriptions and Specifications

11.6.4 Insulet Corp Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Insulet Corp Recent Developments

11.7 Valeritas

11.7.1 Valeritas Corporation Information

11.7.2 Valeritas Business Overview

11.7.3 Valeritas Drug-releasing Pump Product Models, Descriptions and Specifications

11.7.4 Valeritas Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Valeritas Recent Developments

11.8 Microport

11.8.1 Microport Corporation Information

11.8.2 Microport Business Overview

11.8.3 Microport Drug-releasing Pump Product Models, Descriptions and Specifications

11.8.4 Microport Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Microport Recent Developments

11.9 Celanese Healthcare

11.9.1 Celanese Healthcare Corporation Information

11.9.2 Celanese Healthcare Business Overview

11.9.3 Celanese Healthcare Drug-releasing Pump Product Models, Descriptions and Specifications

11.9.4 Celanese Healthcare Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Celanese Healthcare Recent Developments

11.10 Sonceboz

11.10.1 Sonceboz Corporation Information

11.10.2 Sonceboz Business Overview

11.10.3 Sonceboz Drug-releasing Pump Product Models, Descriptions and Specifications

11.10.4 Sonceboz Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Sonceboz Recent Developments

11.11 Enable Injections

11.11.1 Enable Injections Corporation Information

11.11.2 Enable Injections Business Overview

11.11.3 Enable Injections Drug-releasing Pump Product Models, Descriptions and Specifications

11.11.4 Enable Injections Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Enable Injections Recent Developments

11.12 Ypsomed

11.12.1 Ypsomed Corporation Information

11.12.2 Ypsomed Business Overview

11.12.3 Ypsomed Drug-releasing Pump Product Models, Descriptions and Specifications

11.12.4 Ypsomed Drug-releasing Pump Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Ypsomed Recent Developments

muLu

12 Value Chain and Supply-Chain Analysis

12.1 Drug-releasing Pump Industry Chain

12.2 Drug-releasing Pump Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Drug-releasing Pump Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Drug-releasing Pump Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

muLu

13 Drug-releasing Pump Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

muLu

14 Key Findings in the Global Drug-releasing Pump Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Drug-releasing Pump Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Drug-releasing Pump Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Drug-releasing Pump Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Drug-releasing Pump Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Drug-releasing Pump Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Drug-releasing Pump Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Drug-releasing Pump Sales by Region (2020-2025) & (K Units)
Table 8. Global Drug-releasing Pump Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Drug-releasing Pump Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Drug-releasing Pump Sales Share by Manufacturers (2020-2025)
Table 12. Global Drug-releasing Pump Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Drug-releasing Pump Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Drug-releasing Pump by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-releasing Pump as of 2024)
Table 16. Global Drug-releasing Pump Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Drug-releasing Pump Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Drug-releasing Pump Manufacturing Base and Headquarters
Table 19. Global Drug-releasing Pump Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Drug-releasing Pump Sales by Type (2020-2025) & (K Units)
Table 23. Global Drug-releasing Pump Sales by Type (2026-2031) & (K Units)
Table 24. Global Drug-releasing Pump Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Drug-releasing Pump Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Drug-releasing Pump ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Drug-releasing Pump Sales by Application (2020-2025) & (K Units)
Table 29. Global Drug-releasing Pump Sales by Application (2026-2031) & (K Units)
Table 30. Drug-releasing Pump High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Drug-releasing Pump Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Drug-releasing Pump Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Drug-releasing Pump ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Drug-releasing Pump Growth Accelerators and Market Barriers
Table 37. North America Drug-releasing Pump Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Drug-releasing Pump Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Drug-releasing Pump Growth Accelerators and Market Barriers
Table 40. Europe Drug-releasing Pump Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Drug-releasing Pump Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Drug-releasing Pump Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Drug-releasing Pump Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Drug-releasing Pump Growth Accelerators and Market Barriers
Table 45. Southeast Asia Drug-releasing Pump Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Drug-releasing Pump Investment Opportunities and Key Challenges
Table 47. Central and South America Drug-releasing Pump Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Drug-releasing Pump Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Drug-releasing Pump Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Medtronic Corporation Information
Table 51. Medtronic Description and Major Businesses
Table 52. Medtronic Product Models, Descriptions and Specifications
Table 53. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Medtronic Sales Value Proportion by Product in 2024
Table 55. Medtronic Sales Value Proportion by Application in 2024
Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 57. Medtronic Drug-releasing Pump SWOT Analysis
Table 58. Medtronic Recent Developments
Table 59. Johnson & Johnson Corporation Information
Table 60. Johnson & Johnson Description and Major Businesses
Table 61. Johnson & Johnson Product Models, Descriptions and Specifications
Table 62. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Johnson & Johnson Sales Value Proportion by Product in 2024
Table 64. Johnson & Johnson Sales Value Proportion by Application in 2024
Table 65. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
Table 66. Johnson & Johnson Drug-releasing Pump SWOT Analysis
Table 67. Johnson & Johnson Recent Developments
Table 68. Roche Corporation Information
Table 69. Roche Description and Major Businesses
Table 70. Roche Product Models, Descriptions and Specifications
Table 71. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Roche Sales Value Proportion by Product in 2024
Table 73. Roche Sales Value Proportion by Application in 2024
Table 74. Roche Sales Value Proportion by Geographic Area in 2024
Table 75. Roche Drug-releasing Pump SWOT Analysis
Table 76. Roche Recent Developments
Table 77. SOOIL Corporation Information
Table 78. SOOIL Description and Major Businesses
Table 79. SOOIL Product Models, Descriptions and Specifications
Table 80. SOOIL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. SOOIL Sales Value Proportion by Product in 2024
Table 82. SOOIL Sales Value Proportion by Application in 2024
Table 83. SOOIL Sales Value Proportion by Geographic Area in 2024
Table 84. SOOIL Drug-releasing Pump SWOT Analysis
Table 85. SOOIL Recent Developments
Table 86. Tandem Diabetes care Corporation Information
Table 87. Tandem Diabetes care Description and Major Businesses
Table 88. Tandem Diabetes care Product Models, Descriptions and Specifications
Table 89. Tandem Diabetes care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Tandem Diabetes care Sales Value Proportion by Product in 2024
Table 91. Tandem Diabetes care Sales Value Proportion by Application in 2024
Table 92. Tandem Diabetes care Sales Value Proportion by Geographic Area in 2024
Table 93. Tandem Diabetes care Drug-releasing Pump SWOT Analysis
Table 94. Tandem Diabetes care Recent Developments
Table 95. Insulet Corp Corporation Information
Table 96. Insulet Corp Description and Major Businesses
Table 97. Insulet Corp Product Models, Descriptions and Specifications
Table 98. Insulet Corp Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Insulet Corp Recent Developments
Table 100. Valeritas Corporation Information
Table 101. Valeritas Description and Major Businesses
Table 102. Valeritas Product Models, Descriptions and Specifications
Table 103. Valeritas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Valeritas Recent Developments
Table 105. Microport Corporation Information
Table 106. Microport Description and Major Businesses
Table 107. Microport Product Models, Descriptions and Specifications
Table 108. Microport Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Microport Recent Developments
Table 110. Celanese Healthcare Corporation Information
Table 111. Celanese Healthcare Description and Major Businesses
Table 112. Celanese Healthcare Product Models, Descriptions and Specifications
Table 113. Celanese Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Celanese Healthcare Recent Developments
Table 115. Sonceboz Corporation Information
Table 116. Sonceboz Description and Major Businesses
Table 117. Sonceboz Product Models, Descriptions and Specifications
Table 118. Sonceboz Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Sonceboz Recent Developments
Table 120. Enable Injections Corporation Information
Table 121. Enable Injections Description and Major Businesses
Table 122. Enable Injections Product Models, Descriptions and Specifications
Table 123. Enable Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Enable Injections Recent Developments
Table 125. Ypsomed Corporation Information
Table 126. Ypsomed Description and Major Businesses
Table 127. Ypsomed Product Models, Descriptions and Specifications
Table 128. Ypsomed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Ypsomed Recent Developments
Table 130. Key Raw Materials Distribution
Table 131. Raw Materials Key Suppliers
Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 133. Milestones in Production Technology Evolution
Table 134. Distributors List
Table 135. Market Trends and Market Evolution
Table 136. Market Drivers and Opportunities
Table 137. Market Challenges, Risks, and Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Drug-releasing Pump Product Picture
Figure 2. Global Drug-releasing Pump Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Open-loop System Product Picture
Figure 4. Close-loop System Product Picture
Figure 5. Global Drug-releasing Pump Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Public Hospital
Figure 7. Private Hospital
Figure 8. Drug-releasing Pump Report Years Considered
Figure 9. Global Drug-releasing Pump Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 11. Global Drug-releasing Pump Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Drug-releasing Pump Revenue Market Share by Region (2020-2031)
Figure 13. Global Drug-releasing Pump Sales (2020-2031) & (K Units)
Figure 14. Global Drug-releasing Pump Sales (CAGR) by Region (2020-2031) (K Units)
Figure 15. Global Drug-releasing Pump Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Drug-releasing Pump Sales Volume Market Share in 2024
Figure 17. Global Drug-releasing Pump Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Open-loop System Revenue Market Share by Manufacturer in 2024
Figure 20. Close-loop System Revenue Market Share by Manufacturer in 2024
Figure 21. Global Drug-releasing Pump Sales Market Share by Type (2020-2031)
Figure 22. Global Drug-releasing Pump Revenue Market Share by Type (2020-2031)
Figure 23. Global Drug-releasing Pump Sales Market Share by Application (2020-2031)
Figure 24. Global Drug-releasing Pump Revenue Market Share by Application (2020-2031)
Figure 25. North America Drug-releasing Pump Sales YoY (2020-2031) & (K Units)
Figure 26. North America Drug-releasing Pump Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Drug-releasing Pump Sales Revenue (US$ Million) in 2024
Figure 28. North America Drug-releasing Pump Sales Volume (K Units) by Type (2020- 2031)
Figure 29. North America Drug-releasing Pump Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Drug-releasing Pump Sales Volume (K Units) by Application (2020-2031)
Figure 31. North America Drug-releasing Pump Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Drug-releasing Pump Sales YoY (2020-2031) & (K Units)
Figure 36. Europe Drug-releasing Pump Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Drug-releasing Pump Sales Revenue (US$ Million) in 2024
Figure 38. Europe Drug-releasing Pump Sales Volume (K Units) by Type (2020-2031)
Figure 39. Europe Drug-releasing Pump Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Drug-releasing Pump Sales Volume (K Units) by Application (2020-2031)
Figure 41. Europe Drug-releasing Pump Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 43. France Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Drug-releasing Pump Sales YoY (2020-2031) & (K Units)
Figure 48. Asia-Pacific Drug-releasing Pump Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Drug-releasing Pump Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Drug-releasing Pump Sales Volume (K Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Drug-releasing Pump Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Drug-releasing Pump Sales Volume (K Units) by Application (2020-2031)
Figure 53. Asia-Pacific Drug-releasing Pump Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 58. India Drug-releasing Pump Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Drug-releasing Pump Sales YoY (2020-2031) & (K Units)
Figure 60. Central and South America Drug-releasing Pump Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Drug-releasing Pump Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Drug-releasing Pump Sales Volume (K Units) by Type (2021-2031)
Figure 63. Central and South America Drug-releasing Pump Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Drug-releasing Pump Sales Volume (K Units) by Application (2020-2031)
Figure 65. Central and South America Drug-releasing Pump Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Drug-releasing Pump Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Drug-releasing Pump Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Drug-releasing Pump Sales YoY (2020-2031) & (K Units)
Figure 69. Middle East and Africa Drug-releasing Pump Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Drug-releasing Pump Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Drug-releasing Pump Sales Volume (K Units) by Type (2021-2031)
Figure 72. South America Drug-releasing Pump Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Drug-releasing Pump Sales Volume (K Units) by Application (2020-2031)
Figure 74. Middle East and Africa Drug-releasing Pump Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Drug-releasing Pump Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Drug-releasing Pump Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Drug-releasing Pump Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Drug-releasing Pump Revenue (2020-2025) & (US$ Million)
Figure 79. Drug-releasing Pump Industry Chain Mapping
Figure 80. Regional Drug-releasing Pump Manufacturing Base Distribution (%)
Figure 81. Global Drug-releasing Pump Production Market Share by Region (2020-2031)
Figure 82. Drug-releasing Pump Production Process
Figure 83. Regional Drug-releasing Pump Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Drug-releasing Pump market?zhanKai
The top companies in the global Drug-releasing Pump market are Medtronic、Johnson & Johnson、Roche.
den_biaoTiZhungShi

Related Reports

Global Drug-releasing Pump Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published Date: 2025-11-02

Pages: 165 Pages

Report ld: 5343274

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now